ANAB AnaptysBio Inc

USD 23.65 0.04 0.16942
Icon

AnaptysBio Inc (ANAB) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 23.65

+0.04 (+0.17)%

USD 0.64B

0.43M

USD 47.38(+100.32%)

N/A

Icon

ANAB

AnaptysBio Inc (USD)
COMMON STOCK | NSD
USD 23.65
0.00 0
Take a Tour
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.64B

N/A

USD 23.65

AnaptysBio Inc (ANAB) Stock Forecast

Show ratings and price targets of :
USD 47.38
(+100.32%)

Based on the AnaptysBio Inc stock forecast from 7 analysts, the average analyst target price for AnaptysBio Inc is USD 47.38 over the next 12 months. AnaptysBio Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of AnaptysBio Inc is Very Bearish, which is based on 0 positive signals and 5 negative signals. At the last closing, AnaptysBio Inc’s stock price was USD 23.65. AnaptysBio Inc’s stock price has changed by -0.34% over the past week, +1.03% over the past month and +26.47% over the last year.

No recent analyst target price found for AnaptysBio Inc
No recent average analyst rating found for AnaptysBio Inc

Company Overview AnaptysBio Inc

AnaptysBio, Inc., a clinical-stage biotechnology company, focuses in delivering immunology therapeutics. Its products include Rosnilimab, an IgG1 antibody that targets PD-1+ T cells, resulting in their agonism or depletion, broadly impacting pathogenic drivers of autoimmune and i...Read More

https://www.anaptysbio.com

10770 Wateridge Circle, San Diego, CA, United States, 92121-5801

117

December

USD

USA

Adjusted Closing Price for AnaptysBio Inc (ANAB)

Loading...

Unadjusted Closing Price for AnaptysBio Inc (ANAB)

Loading...

Share Trading Volume for AnaptysBio Inc Shares

Loading...

Compare Performance of AnaptysBio Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for ANAB

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To AnaptysBio Inc (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc -1.75 (-0.36%) USD124.65B 31.35 20.00

ETFs Containing ANAB

Symbol Name ANAB's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About AnaptysBio Inc (ANAB) Stock

Based on ratings from 7 analysts AnaptysBio Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Very Bearish. The stock has 6 buy, sell and 2 hold ratings.

Unfortunately we do not have enough data on ANAB's stock to indicate if its a good dividend stock.

Based on targets from 7 analysts, the average taret price for ANAB is USD 47.38 over the next 12 months. The maximum analyst target price is USD 80 while the minimum anlayst target price is USD 28.

ANAB stock's Price/Earning ratio is 95.42. Our analysis grades ANAB stock's Price / Earning ratio at F. This means that ANAB stock's Price/Earning ratio is above 90% of the stocks in the Biotechnology sector in the NSD exchange. Based on this ANAB may be a overvalued for its sector.

The last closing price of ANAB's stock was USD 23.65.

The most recent market capitalization for ANAB is USD 0.64B.

Based on targets from 7 analysts, the average taret price for ANAB is projected at USD 47.38 over the next 12 months. This means that ANAB's stock price may go up by +100.32% over the next 12 months.

We can't find any ETFs which contains AnaptysBio Inc's stock.

As per our most recent records AnaptysBio Inc has 117 Employees.

AnaptysBio Inc's registered address is 10770 Wateridge Circle, San Diego, CA, United States, 92121-5801. You can get more information about it from AnaptysBio Inc's website at https://www.anaptysbio.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...